[
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Thrombin-aptamer",
    "New Linker name":"Thrombin aptamer",
    "Clinical sample":"Adtevak",
    "Target":"α Thrombin",
    "Disease indication":"Thrombosis",
    "Sequence":"5'-GGGAACAAAGCUGAAGUACUUACCC-3'",
    "Length":25,
    "GC content":0.48,
    "Affinity":"Kd:  0.54±0.1 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/7518917\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Interleukin-6-receptor-domain-3-(IL-6R-D3)-aptamer.html",
    "New Linker name":"Interleukin-6 receptor domain 3 (IL-6R D3)-aptamer",
    "Clinical sample":"Serum",
    "Target":"IL-6R",
    "Disease indication":"Immune diseases",
    "Sequence":"5'-GGAAGAAAGAGGUCUGAGACAUUCUUAAAAACGGCCCAUCGUUUGGCGCUGUGGGAGUGGAGGGUGGAUGGUGUUAAGCGAUUGGCUUCUGGAGUUGACGUUGCUU-3'",
    "Length":106,
    "GC content":0.51,
    "Affinity":"Kd: 34.8±5.8 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/26383776\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/IL-17A-aptamer.html",
    "New Linker name":"IL-17A aptamer",
    "Clinical sample":"Serum",
    "Target":"IL‐17A",
    "Disease indication":"Inflammation",
    "Sequence":"5'-GGUCUAGCCGGAGGAGUCAGUAAUCGGUAGACC-3'",
    "Length":33,
    "GC content":0.58,
    "Affinity":"Kd: 48.5 pM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/20967861\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/E2-aptamer",
    "New Linker name":"Aβ aptamer",
    "Clinical sample":"Cerebrospinal fluid",
    "Target":"Amyloid beta-peptide",
    "Disease indication":"Alzheimers disease",
    "Sequence":"5'-GGGAUGUUCUAGGCGGUUGAUGAUUUGGGGUGUCGGGCGAUUUUUAGGGUUGGGCCAGGCCGUCAUCCAGAGUAGCAUAAUUGAUCCGA-3'",
    "Length":89,
    "GC content":0.5281,
    "Affinity":"Kd: 10.9 μM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/19668864\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/CEA-aptamer.html",
    "New Linker name":"CEA aptamer",
    "Clinical sample":"Excrement，Serum ect.",
    "Target":"CEA",
    "Disease indication":"Gastric cancer",
    "Sequence":"5'-GGGUCGUGUCGGAUCCUGCGAAGGGGGGCAGAGGUUUGACGCGAGAAAGCUUCUAAGGUAACGAU-3'",
    "Length":65,
    "GC content":0.5692,
    "Affinity":"Kd: 16.5 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/30303958\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Escherichia-coli-aptamer",
    "New Linker name":"Escherichia coli aptamer",
    "Clinical sample":"Urine",
    "Target":"Escherichia coli",
    "Disease indication":"Infection",
    "Sequence":"5'-GGGAUACCAGCUUAUUCAAUUUGAUUCCAUCUUCCUGGACUGUCGAAAAUUCAGUAUCGGGAGGUUACGUAUUUGGUUUAUAGAUAGUAAGUGCAAUCU-3'",
    "Length":99,
    "GC content":0.3838,
    "Affinity":"Kd: 110 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/22166202\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Dopamine-aptamer.html",
    "New Linker name":"Dopamine aptamer",
    "Clinical sample":"Serum",
    "Target":"Dopamine",
    "Disease indication":"Parkinson's Disease",
    "Sequence":"5'-GGGAAUUCCGCGUGUGCGCCGCGGAAGACGUUGGAAGGAUAGAUACCUACAACGGGGAAUAUAGAGGCCAGCACAUAGUGAGGCCCUCCUCCC-3'",
    "Length":93,
    "GC content":0.5856,
    "Affinity":"Kd: 2.8 µM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/9245404\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Tyr-1-aptamer",
    "New Linker name":"L-tyrosine aptamer",
    "Clinical sample":"Serum",
    "Target":"L-tyrosine",
    "Disease indication":"Phenylketonuria",
    "Sequence":"5'-GGGAAGCUUGUACAGGGGGCAGUCAACUCGUGCGAUCGUGAAAACGGGGCAAGAUGGCCUUACAGCGGUCAAUACGGGGGUCAUCAGAUAGGGAGGCCCUCCUGGUGGUCCGUUCGGGAUCCUC-3'",
    "Length":124,
    "GC content":0.5968,
    "Affinity":"Kd: 35 μM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/10786843\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/DP3-aptamer",
    "New Linker name":"Neuropeptide Y aptamer",
    "Clinical sample":"Serum",
    "Target":"Neuropeptide Y",
    "Disease indication":"Angiocardiopathy",
    "Sequence":"5'-UCGGAGAAAGGGAAGCUUGAGCAGCAGGAGGGCCGGCGUUAGGGUUAGCGAGCCGAUUGAAAGAAGAAGGAACGAGCGUACGGAUCCGAUC-3'",
    "Length":91,
    "GC content":0.5714,
    "Affinity":"Kd: 0.37 μM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/11756401\/"
  },
  {
    "Linker":"https:\/\/aptamer.ribocentre.org\/_posts\/Cell-line-Hep3B-CD133-aptamer",
    "New Linker name":"Cell line Hep3B CD133 aptamer",
    "Clinical sample":"Cellular tissue",
    "Target":"CD133",
    "Disease indication":"Cancer",
    "Sequence":"A15 aptamer: 5'-CCCUCCUACAUAGGG-3'\nB19 aptamer: 5'-CAGAACGUAUACUAUUCUG-3'",
    "Length":"15\n19",
    "GC content":"60%\n37%",
    "Affinity":"Kd: 83.2±82.9 nM\nKd: 145.1±75.4 nM",
    "References":"https:\/\/pubmed.ncbi.nlm.nih.gov\/23196060\/"
  }
]